Phimosis
|
phenotype |
Male Urogenital Diseases
|
Finding
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Astrocytosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
37
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Serum gamma-glutamyl transferase measurement
|
phenotype |
|
Laboratory Procedure
|
54
|
108
|
0.100 |
None |
1.000 |
2 |
1
|
2011 |
2018 |
Alveolitis
|
disease |
Skin and Connective Tissue Diseases; Respiratory Tract Diseases
|
Disease or Syndrome
|
63
|
|
0.010 |
None |
1.000 |
1 |
|
1990 |
1990 |
Respiratory Function Tests
|
phenotype |
|
Diagnostic Procedure
|
67
|
108
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
peak expiratory flow (procedure)
|
phenotype |
|
Laboratory Procedure
|
74
|
119
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Gliosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
102
|
3
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
DOSAGE-SENSITIVE SEX REVERSAL
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
159
|
12
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Dejerine-Sottas Disease (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
176
|
45
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Acute infectious disease
|
group |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
198
|
5
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Reticulocyte count (procedure)
|
phenotype |
|
Laboratory Procedure
|
234
|
474
|
0.100 |
None |
1.000 |
1 |
2
|
2016 |
2016 |
Forced expiratory volume function
|
phenotype |
|
Organ or Tissue Function
|
272
|
1169
|
0.100 |
None |
1.000 |
2 |
2
|
2012 |
2019 |
Arthritis, Psoriatic
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
450
|
89
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Hyperalgesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
451
|
4
|
0.200 |
None |
1.000 |
2 |
|
2004 |
2005 |
Inflammation
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
467
|
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Primary biliary cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
478
|
667
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Metastatic melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
504
|
42
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Influenza A
|
disease |
|
Disease or Syndrome
|
563
|
19
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Dermatologic disorders
|
group |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
617
|
21
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Ankylosing spondylitis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
710
|
609
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
717
|
1599
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Pancreatic Neoplasm
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
764
|
20
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Attention deficit hyperactivity disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
842
|
420
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |